HRF Award Seeks Changemakers Tackling Canada's Health Inequities

OTTAWA, ON – April 23, 2026 – The Health Research Foundation (HRF) of Innovative Medicines Canada has officially opened the call for nominations for its 2026 Diversity and Equity in Research Award, marking a nationwide search for researchers whose work is dismantling barriers and building a more equitable healthcare system for all Canadians.

Now in its fourth year, the annual award celebrates individuals making significant strides in ensuring health research and access to care reflect the true diversity of Canada's population. The recipient will be celebrated at the HRF Awards Reception in Toronto on November 17, an event that recognizes leaders transforming the landscape of Canadian health.

Champions of Change: The Legacy of Past Honorees

The award's previous recipients offer a powerful testament to the real-world impact of health equity research. Their work moves beyond academic theory to directly address life-and-death disparities affecting marginalized communities.

Most recently, the award recognized Dr. Juliet Daniel, a pioneering cancer biologist whose research has illuminated the stark racial disparities in cancer outcomes. Dr. Daniel’s work focuses on triple-negative breast cancer (TNBC), an aggressive form of the disease that disproportionately impacts women of African and Hispanic descent. By investigating the biological underpinnings of this disparity, her research is paving the way for targeted treatments and improved diagnostics that could save lives in communities that have long faced worse prognoses.

Similarly, the 2024 honoree, Dr. Sonia Anand, is a trailblazer in cardiovascular research. Her work has been instrumental in moving Canadian medicine away from a "one size fits all" approach. As a Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, Dr. Anand has led extensive studies with First Nations communities and various ethnic groups to understand the unique social and genetic determinants of disease. Her findings are crucial for developing precision health strategies and community-based interventions that are culturally appropriate and scientifically sound.

This legacy began with the inaugural recipient, Dr. Oluwabukola Salami, whose transformative research has focused on the health of migrants and Black populations. Dr. Salami has led projects valued at over $230 million, investigating everything from immigrant mental health to barriers in healthcare access for immigrant children. Beyond her research, she founded Canada's first interdisciplinary mentorship program for Black youth at a university, actively building the pipeline for the next generation of diverse researchers.

Confronting the Cracks in Canadian Healthcare

The work celebrated by the HRF award is a direct response to the persistent and deeply rooted inequities within Canada's healthcare system. Despite its universal structure, significant gaps in health outcomes remain. Indigenous, Black, and other racialized communities continue to experience poorer health, reduced life expectancy, and higher rates of chronic illness.

Experts point to the powerful influence of the social determinants of health—factors like income, education, race, and social status—which create significant barriers. For example, lower-income Canadians experience fewer healthy years of life than their higher-income counterparts. Access remains a critical hurdle, with Indigenous peoples facing systemic obstacles and reports showing Black women in Ontario are less likely to have a family doctor than non-racialized women.

These challenges are compounded by systemic racism and a critical lack of comprehensive, race-based health data, which limits the ability to monitor disparities and design effective interventions. The HRF award directly targets this issue by celebrating those who push for progress.

"The HRF Diversity and Equity in Research Award recognizes researchers who are challenging longstanding barriers in health research and ensuring it better reflects and serves the diversity of Canada's population," said Christine Elliott, Chair of the HRF Board of Directors, in the official announcement. "Their leadership is helping to build a more inclusive, responsive, and effective health system."

A Coordinated Effort for a More Inclusive System

The HRF award is a prominent part of a larger, growing movement across Canada to embed equity, diversity, and inclusion into the fabric of health research. It complements major initiatives from bodies like the Canadian Institutes of Health Research (CIHR), which has implemented a framework to foster an anti-racist and inclusive research environment. Organizations like the Canadian Cancer Society and private sector players like Novartis Canada have also launched grant programs specifically aimed at funding projects that tackle health disparities.

The HRF, a non-profit dedicated to applied health-systems research, is uniquely positioned to drive this change through its partnership with Innovative Medicines Canada (IMC), the national association for Canada's pharmaceutical industry. This collaboration signifies a powerful alignment between non-profit goals and industry commitment. IMC's 45 member companies invest approximately $3.2 billion in R&D in Canada annually and have contributed over $30 million to the HRF's work, providing substantial financial backing for research that reimagines how healthcare is delivered and experienced.

How Diverse Research Fuels Smarter Medicine

The push for equity in research is not only a matter of social justice—it is fundamental to scientific excellence and medical innovation. For decades, clinical trials for new medicines often failed to include diverse populations, leading to gaps in knowledge about how treatments affect different groups. Promoting diversity is essential for ensuring new therapies are safe and effective for everyone.

The work of researchers like Dr. Daniel and Dr. Anand demonstrates this principle in action. By focusing on underrepresented populations, they uncover novel biological mechanisms and risk factors, which in turn fuel the development of more precise and effective medicines. This approach, known as population precision health, tailors healthcare to the specific needs of communities, promising better outcomes and a more efficient health system.

By spotlighting and supporting these changemakers, the HRF and IMC are helping to build trust with communities that have been historically marginalized by the healthcare system. This fosters a more inclusive environment where more people are willing to participate in research, creating a virtuous cycle that accelerates the development of innovative medicines for all Canadians.

The search is now on for the next leader to be recognized for their contributions. The Health Research Foundation is inviting nominations of outstanding researchers who are driving meaningful change for underrepresented populations in Canada. Nominations remain open until July 14, 2026. More information on eligibility and the submission process can be found on the foundation's website at www.hrf-frs.com.